Home
Search
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Trump’s “scrambling” for drug price controls
Bio.News  •  January 27, 2020
If you needed a reminder of the importance of washing your hands during flu season, researchers say it's one of the best things you can do right now to protect yourself against the Wuhan coronavirus, reports the New York Times. (And yes, we'll be first in line to get a vaccine when one of our industry's innovators creates it.)  The virus isn't the only bad news today: Trump's reigniting plans for an international price index for drugs, and corporations are increasingly concerned about the impact of climate change on their businesses and the global economy. The good news? The biotech sector is poised to play a big role, in stopping both a global epidemic and a climate crisis. Here are 763 words, which you can read in 2 minutes, 46 seconds.
Read More

The state of play on drug pricing and the election
Bio.News  •  January 24, 2020
In case you need some weekend reading, here are 815 words on the state of play on drug pricing and where things stand in the election, which you can read in just about 4 minutes. We'll see you (and the House) on Monday.
Read More

More than 60% of infections jump from animals to humans
Bio.News  •  January 23, 2020
In case you missed it, it’s One Health Awareness Month—and since things are a bit slow in Washington with impeachment taking over, we’re doing a Good Day BIO takeover to tell you more about this initiative and why it’s important.
Read More

The superbug crisis heats up
Bio.News  •  January 22, 2020
Day 2 of the impeachment trial is taking over Washington – but we're still super concerned about superbugs, and also revisiting Trump's recent comments to farmers and what they mean. Here are 695 words, 3 minutes, 28 seconds.
Read More

Why the American economy needs biotech
Bio.News  •  January 21, 2020
America’s third-ever impeachment trial begins…and POTUS is hangin' in the Swiss Alps.  While Washington’s focused on impeachment, we're taking a look at Trump's speech at Davos as well as new health care spending data, in 819 words, or 2 minutes, 59 seconds. 
Read More

State Government Affairs Outlook 2020
Bio.News  •  January 20, 2020
Today’s Martin Luther King Jr. Day, and the federal government is closed to honor his legacy. But while we’re taking a breather from the news grind in Washington, science doesn’t stop—so we’re taking the opportunity to give you a look at what to expect in state legislatures this year, from Patrick J. Plues, BIO’s VP of State Government Affairs. We’ll be back tomorrow with the usual daily news.
Read More

You need to know about this obscure Delaware court case
Bio.News  •  January 17, 2020
We’re closing out the week with the details of an obscure court case in Delaware that could have a huge impact on biotechs, as well as a look at one researcher’s work to feed the world, in 766 words, or 3 minutes, 49 seconds. On Monday, we’re off to honor Martin Luther King Jr., but we’ll be publishing a special edition with a look at what to expect in the state legislatures in 2020. We’ll be back to regularly scheduled programing on Tuesday.
Read More

You need to know about this obscure Delaware court case
Bio.News  •  January 17, 2020
We’re closing out the week with the details of an obscure court case in Delaware that could have a huge impact on biotechs, as well as a look at one researcher’s work to feed the world, in 766 words, or 3 minutes, 49 seconds. On Monday, we’re off to honor Martin Luther King Jr., but we’ll be publishing a special edition with a look at what to expect in the state legislatures in 2020. We’ll be back to regularly scheduled programing on Tuesday.
Read More

Two big things for biotech trade and investment
Bio.News  •  January 16, 2020
Some positive news today for the future of biotech trade and investment. First, the United States and China signed the “phase one” agreement, and we have details on what it means for biotech. Then, we take a look at the final CFIUS regulations, which, thanks to our advocacy work, turned out to be much better for the industry and our ability to attract investment in new cures. Here are 771 words, which you can read in 3 minutes, 51 seconds.
Read More

China Phase I Agreement Represents Important Step Towards Addressing Biotech Issues
Press Release  •  January 15, 2020
Washington, D.C. (January 15, 2020) – BIO President and CEO Jim Greenwood released the following statement today regarding the signing of Phase One of the trade agreement with China: “Trade issues with China have long been a priority for BIO and our members. We appreciate the Administration’s hard work and leadership and welcome the completion of this important first phase of the agreement. “We are currently reviewing the details, but we are pleased to see important commitments for agricultural biotechnology, biopharmaceuticals, and GM microorganisms, in addition to commitments related to forced technology transfer and intellectual property. We look forward to working closely with the Administration to monitor the implementation and enforcement of these provisions.  “Completion of the phase-one agreement is an important first step.  More work is needed as we move to the next phase of this important negotiation. Our trade relationship with China is vital for America’s farmers, our scientists and our entrepreneurs. We must build on this momentum to ensure we have the type of 21st Century agreement with China that is balanced, enforceable and reflective of key sectors of America’s economy and our future.” 
Read More